Early Development Portfolio Leader-Pulmonary-2153140811
Description
Janssen Research & Development, L.L.C., a division of Johnson & Johnson's Family of Companies is recruiting for an Early Development Portfolio Team Leader,Pulmonary located in Spring House, PA.
Janssen Research & Development, L.L.C. develops treatments that improve the health and lifestyles of people worldwide. Research and development areas encompass novel targets in neurologic disorders, gastroenterology, oncology, infectious disease, diabetes, hematology, metabolic disorders, immunologic disorders, and reproductive medicine.
Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), cardiovascular disease, general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health. Our ultimate goal is to help people live healthy lives. We have produced and marketed many first-in-class prescription medications and are poised to serve the broad needs of the healthcare market – from patients to practitioners, from clinics to hospitals. For more about Janssen Pharmaceuticals, Inc., one of the Pharmaceutical Companies of Johnson & Johnson, visit www.janssenpharmaceuticalsinc.com
Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer.
The Early Development Portfolio Leader position will direct Pulmunary Disease Area focused early compound development and provide strategic direction to the Compound Early Development Teams(CDT) acting as the primary spokesperson and the champion for Pulmunary Disease Area driven initiatives. This position will also manage external alliances leading co-development or licensing partnerships.
Key responsibilities include being responsible for managing a portfolio of multiple compounds aligned to Pulmunary Disease Area specific indications; Lead cross functional teams responsible for early development of compounds within a Pulmunary Disease Area; Leads major strategic alliances to ensure value creation and optimal alliance performance; Manage the complexity of internal/external development with highest degree of: Regulatory/commercial uncertainty, Safety issues (high or low risk drug), Pre-clinical issues, Formulation issues; Plan effectively to ensure CDTs have the resources to achieve their goals; Presents strategic issues and phase transition proposals at governance boards.
Qualifications
Advanced Degree (Ph.D., M.D., MBA) is required
At least 10 years of industry or academia experience is required
At least 3 years of drug development experience is required
Previous experience in leadership role is preferred
BE VITAL in your career, Be seen for the talent you bring to your work. Explore opportunities within the Johnson & Johnson Family of Companies.
J2W: LI NA
J2W:BIO
J2W:MZ
J2W:NSJ
Primary Location:North America-United States-Pennsylvania-Spring House
Organization: Janssen Research & Development, LLC. (6084)
Job Function: R&D
Certain sites within the Johnson & Johnson Family of Companies participate in E-Verify as appropriate in accordance with Company guidelines and federal or state law. To learn more about the government sponsored program and to see a list of the sites that are currently enrolled, please click here.
Johnson and Johnson Family of Companies are equal opportunity employers, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, protected veteran status, or disability status, or any other characteristic protected by law.
EEO is the Law
EEO is the Law GINA Supplement